ARCT – arcturus therapeutics holdings inc. (US:NASDAQ)
Stock Stats
News
Arcturus Therapeutics to Attend Upcoming Investor Conference
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $9.00. They now have a "neutral" rating on the stock.
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at Piper Sandler from $140.00 to $72.00. They now have an "overweight" rating on the stock.
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at HC Wainwright from $12.00 to $9.00. They now have a "neutral" rating on the stock.
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2025 Earnings Call Highlights: Navigating ... [Yahoo! Finance]
Form SCHEDULE 13G Arcturus Therapeutics Filed by: BALYASNY ASSET MANAGEMENT L.P.
Form SCHEDULE 13G/A Arcturus Therapeutics Filed by: Amova Asset Management Americas, Inc.
Form 10-Q Arcturus Therapeutics For: Sep 30
Form NT 10-Q Arcturus Therapeutics For: Sep 30
Form 8-K Arcturus Therapeutics For: Nov 10
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.